Crescent Biopharma, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 30/07/2026 | Mar 2026Filed 30/07/2026 | Dec 2025Filed 29/04/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 30/07/2026 | Mar 2025Filed 30/07/2026 | Sep 2024Filed 13/11/2024 | Jun 2024Filed 13/11/2024 |
|---|---|---|---|---|---|---|---|---|
| $0 | $1 | — | — | $0 | $0 | — | — | |
| −$25 | −$23 | −$23 | −$25 | −$22 | −$15 | −$9.8 | −$10 | |
| — | — | — | — | — | −$0.04 | −$0.15 | −$0.16 | |
| — | — | — | — | — | 65 | 64 | 64 |
Trend